Psychemedics Corporation (PMD): Price and Financial Metrics


Psychemedics Corporation (PMD): $6.29

-0.15 (-2.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PMD Stock Summary

  • PMD has a market capitalization of $39,737,803 -- more than approximately only 7.3% of US stocks.
  • PMD's current price/earnings ratio is 96.22, which is higher than 93.07% of US stocks with positive earnings.
  • With a year-over-year growth in debt of -39.07%, Psychemedics Corp's debt growth rate surpasses only 10.42% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Psychemedics Corp, a group of peers worth examining would be ROG, SPNE, BSQR, ICUI, and TELA.
  • Visit PMD's SEC page to see the company's official filings. To visit the company's web site, go to www.psychemedics.com.

PMD Valuation Summary

  • In comparison to the median Healthcare stock, PMD's EV/EBIT ratio is 177.82% lower, now standing at -22.8.
  • Over the past 243 months, PMD's EV/EBIT ratio has gone down 85.4.
  • PMD's price/earnings ratio has moved down 143.8 over the prior 243 months.

Below are key valuation metrics over time for PMD.

Stock Date P/S P/B P/E EV/EBIT
PMD 2021-08-31 2.0 3.5 -31.7 -22.8
PMD 2021-08-30 1.9 3.3 -30.3 -21.9
PMD 2021-08-27 1.9 3.2 -29.3 -21.3
PMD 2021-08-26 1.9 3.3 -30.2 -21.9
PMD 2021-08-25 1.9 3.2 -29.4 -21.4
PMD 2021-08-24 1.8 3.1 -28.2 -20.6

PMD Growth Metrics

    Its 2 year cash and equivalents growth rate is now at -35.65%.
  • Its 3 year net income to common stockholders growth rate is now at 227.22%.
  • The 2 year price growth rate now stands at -76.51%.
Over the past 33 months, PMD's revenue has gone down $18,866,000.

The table below shows PMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 23.808 0.989 0.413
2021-06-30 22.309 -0.117 -1.433
2021-03-31 19.536 -4.083 -3.617
2020-12-31 21.36 -4.083 -3.859
2020-09-30 24.74 -4.275 -3.846
2020-06-30 29.418 -1.11 -2.062

PMD Stock Price Chart Interactive Chart >

Price chart for PMD

PMD Price/Volume Stats

Current price $6.29 52-week high $8.90
Prev. close $6.44 52-week low $6.01
Day low $6.29 Volume 2,000
Day high $6.46 Avg. volume 16,301
50-day MA $6.67 Dividend yield 3.11%
200-day MA $7.36 Market Cap 35.17M

Psychemedics Corporation (PMD) Company Bio


Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. The company was founded in 1985 and is based in Acton, Massachusetts.


PMD Latest News Stream


Event/Time News Detail
Loading, please wait...

PMD Latest Social Stream


Loading social stream, please wait...

View Full PMD Social Stream

Latest PMD News From Around the Web

Below are the latest news stories about Psychemedics Corp that investors may wish to consider to help them evaluate PMD as an investment opportunity.

Is Psychemedics Corporation's (NASDAQ:PMD) Stock On A Downtrend As A Result Of Its Poor Financials?

With its stock down 16% over the past three months, it is easy to disregard Psychemedics (NASDAQ:PMD). Given that stock...

Yahoo | February 16, 2022

Psychemedics Corporation Declares Cash Dividend

ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30th, 2021 to shareholders of record as of December 20th, 2021. As the record shows, the Company paid 94 consecutive dividends (23 ½ years) through the first quarter of 2020, even during the financial crisis in 2008. However, because of the COVID pandem

Yahoo | December 10, 2021

Returns On Capital At Psychemedics (NASDAQ:PMD) Paint A Concerning Picture

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...

Yahoo | November 16, 2021

Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021

ACTON, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2021. The Company’s revenue for the quarter ended September 30, 2021, was $6.7 million versus $5.2 million for the quarter ended September 30, 2020, an increase of 29%. Net income for the quarter ended September 30, 2021, was $0.7 million or $0.13 per diluted share, versu

Yahoo | November 12, 2021

Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results

ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2021. The Company’s revenue for the quarter ended June 30, 2021, was $6.1 million versus $3.3 million for the quarter ended June 30, 2020, an increase of 85%. Net income for the quarter ended June 30, 2021, was $0.1 million or $0.02 per diluted share, versus net loss of $2.1

Yahoo | August 10, 2021

Read More 'PMD' Stories Here

PMD Price Returns

1-mo -4.70%
3-mo -11.41%
6-mo -27.36%
1-year -5.03%
3-year -35.30%
5-year -66.72%
YTD -10.40%
2021 38.89%
2020 -43.25%
2019 -38.19%
2018 -20.09%
2017 -14.14%

PMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6596 seconds.